EOM Pharmaceuticals Holdings, Inc. (OTCMKTS:IMUC) Short Interest Update

EOM Pharmaceuticals Holdings, Inc. (OTCMKTS:IMUC – Get Free Report ) received a large decrease in short interest in the month of July. As of July 31st, there was short interest of 600 shares, a decrease of 14.3% from July 15th’s total of 700 shares. Based on an average daily volume of 2,900 shares, the short interest rate is currently 0.2 days.

EOM Pharmaceuticals stock up 29.1%

Shares of IMUC stock opened at $0.15 on Friday. EOM Pharmaceuticals has a 1 year low of $0.07 and a 1 year high of $0.40. The company’s 50-day simple moving average is $0.16 and its 200-day simple moving average is $0.20.

About EOM Pharmaceuticals

(Get a free report)

Immunocellular Therapeutics, Ltd., a clinical-stage pharmaceutical company, focuses on the development of therapeutic and delivery technologies for the treatment of inflammatory conditions and eye diseases. Its lead clinical active is EOM613, a peptide nucleic acid solution with anti-inflammatory and pro-inflammatory effects on cytokines and chemokines for the treatment of cancer cachexia and rheumatoid arthritis.

Recommended articles

Get daily news and ratings for EOM Pharmaceuticals – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for EOM Pharmaceuticals and related companies with MarketBeat.com ‘s FREE daily email newsletter.